Appetite Suppressants as Adjuncts in the Treatment of Obesity
Tags: OBESITY -- Treatment; APPETITE depressants; HEALTH
Related Articles
- Phen/fen combination for weight control. R.M.D. // Cortlandt Forum;7/25/96, Vol. 9 Issue 7, p137
Provides information on the safety and proper administration of phentermine and fenfluramine used in combination for appetite suppression. Effectiveness in treating obesity; How the agents act as appetite depressants; Recommended use of the agents as part of a comprehensive weight control...
- The weight is over. // Men's Health (10544836);Jun98, Vol. 13 Issue 5, p38
Presents information on Meridia, an anti-obesity drug approved by the United States Food and Drug Administration. How Meridia reduces the hunger of a person; Advantage of Meridia from other anti-obesity drug.
- Orlistat for obesity? // Consumer Reports on Health;Jul99, Vol. 11 Issue 7, p7
Provides information on orlistat, an obesity drug that suppresses appetite. Clinical trial results; Mechanism of action; Side effects; Need for diet and exercise to ensure that weight loss will last.
- Drugs for obesity are last resort treatment. Bower, Hilary // BMJ: British Medical Journal (International Edition);06/07/97, Vol. 314 Issue 7095, p1643
States that appetite suppressant drugs should be prescribed as a last resort treatment for obese patients in Great Britain. Crackdown on inappropriate use of slimming drugs by the Royal College of Physicians of London; Benefits obese patients may get from desfenfluramine; Side effects of taking...
- Efficacy and Tolerability of Orlistat in Obese Patients. Nuovo, Jim // American Family Physician;8/1/2000, Vol. 62 Issue 3, p649
Presents an abstract of the study `Orlistat in the long-term treatment of obesity in primary care settings,' by J. Hauptman, et al., from the February 2000 issue of `Archives of Family Medicine.'
- Double-blind Evaluation of Mazindol in Refractory Obesity. Smith, R.G.; Innes, J.A.; Munro, J.F. // British Medical Journal;8/2/1975, Vol. 3 Issue 5978, p284
Evaluates the effect of mazindol on refractory obesity. Stimulation of the central nervous system; Decrease in body mass index; Role of anorectic agents in the modification of eating habits.
- Health Benefits Of Obesity Drug Were Maintained For Two Years. // RN;May2001, Vol. 64 Issue 5, p114
Presents an abstract of the study `Effect of Sibutramine on Weight Maintenance After Weight Loss: A Randomized Trial,' by W.P.T. James, A. Astrup, et al which appeared in the the 2001 issue of the `Lancet.'
- Pharmacology of Appetite Suppression: Implication for the Treatment of Obesity. Halford, Jason C.G. // Current Drug Targets;Dec2001, Vol. 2 Issue 4, p353
Given the current global epidemic of obesity there is a demand for new anti-obesity drugs to overcome the problem. Many pharmacological agents reduce food intake and significantly decrease body mass when administered to animals but affect feeding behaviour in a profoundly different way...
- OBESITY DRUGS Not a Quick Fix. // USA Today Magazine;Oct2000, Vol. 129 Issue 2665, p6
Provides information on the use of diet pills to reduce the weight of obese patients. Complications and side effects of diet pills; Benefits of diet and exercise therapy; Observation on the lifestyle of obese patients.
